HPLC-MS identification and expression of Candida drug-resistance proteins from African HIV-infected patients

Pedro M D S Abrantes1, Randall Fisher2, Patrick J D Bouic3

  • 1Maternal Endogenous Infections Studies (MEnIS) Research Laboratories, Department of Medical Biosciences, University of the Western Cape, Private Bag X17, Bellville 7535, South Africa.

AIMS Microbiology
|October 28, 2021
PubMed

Insights

Proteomic analysis of Candida isolates from HIV-positive patients reveals drug resistance mechanisms. Key proteins like heat shock and efflux pumps contribute to pathogenicity and antifungal resistance in these individuals.

Area of Science:

  • Mycology
  • Proteomics
  • Infectious Diseases

Background:

  • HIV-positive individuals are susceptible to opportunistic fungal infections, particularly oral candidiasis.
  • Drug resistance in Candida species complicates treatment outcomes in immunocompromised patients.

Purpose of the Study:

  • To identify proteomic differences in oral Candida isolates from HIV-positive African patients.
  • To elucidate the mechanisms underlying fungal pathogenicity and drug resistance.

Main Methods:

  • Proteomic analysis using High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS).
  • Analysis of cell membrane fractions from 40 oral Candida isolates.

Main Results:

  • Heat shock proteins were present in all isolates, mediating fungicidal activity.
  • pH-responsive proteins, ABC multidrug transporter efflux pumps, and estrogen binding proteins were associated with pathogenicity and drug resistance, particularly in *C. albicans*.
  • Ergosterol biosynthesis proteins were identified in four species.

Conclusions:

  • A combination of adherence, invasion, upregulation, and efflux pump mechanisms contributes to Candida colonization and drug resistance in HIV-infected individuals.
  • Understanding these proteomic mechanisms is crucial for developing targeted therapies against drug-resistant candidiasis.

Related Concept Videos